Skip to main content
Caplight Logo









Devigere Biosolutions

Devigere Biosolutions

Private
BangaloreHealthcare & Life Scienceshttps://devigerebiosolutions.com/

Last Round

Seed

May 29, 2024

Total Funding Raised

$4,300

Company Overview

Devigere Biosolutions operates in Healthcare & Life Sciences and is based in Bangalore. Its latest recorded funding round was a Seed round in May 2024.

Devigere Biosolutions is a food technology company that produces sustainable, functional, and clean-label plant protein concentrates derived from Indian pulses.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Sustainable Materials, Clean Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Devigere Biosolutions Comparables

Compare Devigere Biosolutions with similar companies based on industry and business-model similarity.

Devigere Biosolutions comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Proeon Foods
85%
Magronic Contrivance Private Limited
81%
SentiaNova
78%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Devigere Biosolutions Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 29, 2024
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Smitha Devigere

Founder & CEO

Founding Team

For institutional investors. Book with your work email.

Devigere Biosolutions Investors

Notable investors and investment history

Devigere Biosolutions Filings

Explore SEC and related filing metadata, where available.

Devigere Biosolutions filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Devigere Biosolutions's valuation, stock price, and market status.

Is Devigere Biosolutions a public or private company?

Devigere Biosolutions is a private company.

What is the current stock price of Devigere Biosolutions?

Devigere Biosolutions is a private company, so its shares have no public market price. Caplight tracks Devigere Biosolutions's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Devigere Biosolutions worth (valuation)?

Valuation information for Devigere Biosolutions is not publicly available.

Can I buy Devigere Biosolutions stock?

Devigere Biosolutions shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Devigere Biosolutions's last funding round?

Devigere Biosolutions's most recent funding round was Seed on May 29, 2024.

Who are the main investors in Devigere Biosolutions?

Key investors in Devigere Biosolutions include Rainmatter Capital Fund.

Will Devigere Biosolutions IPO soon?

No public IPO plans have been announced for Devigere Biosolutions.

How can I track Devigere Biosolutions secondary market activity?

Caplight tracks bids, offers, and trades in Devigere Biosolutions's shares on secondary markets.

Firmographic Details

HeadquartersBangalore
Employee Range2
Year Founded2020
Last FundingMay 29, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?